共 50 条
- [22] Identification of a Novel Somatic Mutation Leading to Allele Dropout for EGFR L858R Genotyping in Non-Small Cell Lung Cancer [J]. Molecular Diagnosis & Therapy, 2017, 21 : 431 - 436
- [25] EGFR tyrosine kinase inhibitors versus chemotherapy as first-line therapy for non-small cell lung cancer patients with the L858R point mutation [J]. SCIENTIFIC REPORTS, 2016, 6
- [27] Leptomeningeal Metastatic L858R EGFR-mutant Lung Cancer: Prompt Response to Osimertinib in the Absence of T790M-mutation and Effective Subsequent Pulsed Erlotinib [J]. ONCOTARGETS AND THERAPY, 2022, 15 : 659 - 667
- [29] Wighteone exhibits an antitumor effect against EGFR L858R/T790M mutation non-small cell lung cancer [J]. JOURNAL OF CANCER, 2021, 12 (13): : 3900 - 3908